Experienced in Erythema Nodosum

Hiroyuki H. Okamoto

Chuo, JP 
Experienced in Erythema Nodosum
Chuo, JP 
OverviewLocationsClinical Research

Overview

Hiroyuki Okamoto practices in Chuo, Japan. Mr. Okamoto is rated as an Experienced expert by MediFind in the treatment of Erythema Nodosum. His top areas of expertise are Angiosarcoma of the Scalp, Polymorphous Light Eruption, Gastric Lymphoma, Hysterectomy, and Mastectomy.

His clinical research consists of co-authoring 257 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Erythema Nodosum.

Gender
Male

Locations

Chuo, Japan
Other Locations
Tokyo, 1040045, Japan
Chuo, Japan
Chuo, 5408645, Japan
Japan
Osaka, Japan
Anan, 7740017, Japan
Tsukiji, 1040045, Japan
Hirakata, Japan
Kanagawa, Japan
Shiga Prefectural Fisheries Experimental Station, 2138-3, Hikone, 5220057, Japan
Kanazawa, 9200013, Japan
Port Of Nagoya Public Aquarium, Nagoya, 4550033, Japan
Koshigaya, 3438555, Japan
Settsu, 5660022, Japan
Nagakute, 4801195, Japan
Toride, Japan
Moriya, 3020106, Japan
Miemachi, 5190423, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Post Marketing Clinical Trial to Evaluate the Efficacy And Safety Of Ixekizumab in Patients With Generalized Pustular Psoriasis and Erythrodermic Psoriasis
A Multicenter, Open-Label, Post Marketing Clinical Trial to Evaluate the Efficacy And Safety Of Ixekizumab in Patients With Generalized Pustular Psoriasis and Erythrodermic Psoriasis
Enrollment Status: Completed
Publish Date: August 13, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

256 Total Publications

Evaluation of the dosimetric impact and safety of MucoUp as a spacer in gynecologic brachytherapy.
Evaluation of the dosimetric impact and safety of MucoUp as a spacer in gynecologic brachytherapy.
Journal: Brachytherapy
Published: February 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Okamoto's expertise for a condition
ConditionClose
    View All 53 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile